BioCentury
ARTICLE | Clinical News

EMEA to review CTIC's Trisenox MAA

February 2, 2001 8:00 AM UTC

Cell Therapeutics (CTIC) said that the CPMP accepted for review its MAA for Trisenox arsenic trioxide to treat relapsed acute promyelocytic leukemia (APL). Trisenox is approved to treat relapsed or re...